JP2010506932A5 - - Google Patents

Download PDF

Info

Publication number
JP2010506932A5
JP2010506932A5 JP2009533389A JP2009533389A JP2010506932A5 JP 2010506932 A5 JP2010506932 A5 JP 2010506932A5 JP 2009533389 A JP2009533389 A JP 2009533389A JP 2009533389 A JP2009533389 A JP 2009533389A JP 2010506932 A5 JP2010506932 A5 JP 2010506932A5
Authority
JP
Japan
Prior art keywords
debenzoyl
butoxycarbonyl
tert
crystalline
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009533389A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010506932A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/022309 external-priority patent/WO2008051465A2/en
Publication of JP2010506932A publication Critical patent/JP2010506932A/ja
Publication of JP2010506932A5 publication Critical patent/JP2010506932A5/ja
Pending legal-status Critical Current

Links

JP2009533389A 2006-10-20 2007-10-19 結晶性の無水ドセタキセルの製造方法 Pending JP2010506932A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85334106P 2006-10-20 2006-10-20
PCT/US2007/022309 WO2008051465A2 (en) 2006-10-20 2007-10-19 Process for making crystalline anhydrous docetaxel

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013087629A Division JP2013155191A (ja) 2006-10-20 2013-04-18 結晶性の無水ドセタキセルの製造方法

Publications (2)

Publication Number Publication Date
JP2010506932A JP2010506932A (ja) 2010-03-04
JP2010506932A5 true JP2010506932A5 (cg-RX-API-DMAC7.html) 2010-11-25

Family

ID=39325127

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009533389A Pending JP2010506932A (ja) 2006-10-20 2007-10-19 結晶性の無水ドセタキセルの製造方法
JP2013087629A Pending JP2013155191A (ja) 2006-10-20 2013-04-18 結晶性の無水ドセタキセルの製造方法
JP2014233275A Pending JP2015057423A (ja) 2006-10-20 2014-11-18 無水ドセタキセルの製造方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013087629A Pending JP2013155191A (ja) 2006-10-20 2013-04-18 結晶性の無水ドセタキセルの製造方法
JP2014233275A Pending JP2015057423A (ja) 2006-10-20 2014-11-18 無水ドセタキセルの製造方法

Country Status (10)

Country Link
US (2) US7662980B2 (cg-RX-API-DMAC7.html)
EP (2) EP2330101A1 (cg-RX-API-DMAC7.html)
JP (3) JP2010506932A (cg-RX-API-DMAC7.html)
KR (1) KR101266549B1 (cg-RX-API-DMAC7.html)
CN (1) CN101534642A (cg-RX-API-DMAC7.html)
AR (1) AR063347A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007309534B2 (cg-RX-API-DMAC7.html)
CA (2) CA2667416C (cg-RX-API-DMAC7.html)
NZ (1) NZ576355A (cg-RX-API-DMAC7.html)
WO (1) WO2008051465A2 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8703982B2 (en) 2003-03-17 2014-04-22 Phyton Holdings Llc Purification of taxanes
CA2653541C (en) 2005-06-06 2014-12-23 The University Of British Columbia Polymer-based serum albumin substitute
KR20080100264A (ko) * 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법
KR100878455B1 (ko) * 2007-04-10 2009-01-13 한미약품 주식회사 안정한 무수결정형 도세탁셀 및 이의 제조방법
WO2009006590A2 (en) * 2007-07-04 2009-01-08 Dr. Reddy's Laboratories Ltd. Docetaxel process and polymorphs
WO2010059916A2 (en) * 2008-11-20 2010-05-27 Dr. Reddy's Laboratories Ltd. Preparation of docetaxel
PL388144A1 (pl) * 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
US8686165B2 (en) * 2009-11-04 2014-04-01 Emcure Pharmaceuticals Limited Process for preparation of taxane derivatives
KR101149600B1 (ko) * 2009-12-31 2012-05-29 주식회사 삼양제넥스바이오 고순도 무수결정형 도세탁셀 제조방법
EP2542613A4 (en) 2010-03-01 2013-12-11 Univ British Columbia SUBSTITUTED HYPERBRANCHED POLYGLYCEROLS
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
EP2447268A1 (en) 2010-10-29 2012-05-02 INDENA S.p.A. Crystalline form of 13-[(N-tert-butoxycarbonyl)-2'-O-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin III
KR20120096200A (ko) * 2011-02-22 2012-08-30 동아제약주식회사 결정형 도세탁셀 및 이의 제조방법
WO2012131698A1 (en) * 2011-04-01 2012-10-04 Shilpa Medicare Limited Process for preparing docetaxel and its hydrate
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
WO2012160568A1 (en) * 2011-05-23 2012-11-29 Shilpa Medicare Limited Process for preparing docetaxel trihydrate polymorph
JO3685B1 (ar) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
KR101508302B1 (ko) * 2013-06-10 2015-04-06 숭실대학교산학협력단 초음파를 이용한 도세탁셀 수화물 제조방법
EP2865675A1 (en) * 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN107683134B (zh) 2015-05-15 2021-02-23 珠海贝海生物技术有限公司 多西他赛及人血清白蛋白复合物
CN115487312B (zh) 2016-10-27 2025-02-07 珠海贝海生物技术有限公司 多西他赛和人血清白蛋白的中性pH组合物
CN109836401B (zh) * 2017-11-28 2023-02-14 正大天晴药业集团股份有限公司 一种多西他赛的纯化方法
JP7734677B2 (ja) 2020-02-04 2025-09-05 珠海貝海生物技術有限公司 ドセタキセル製剤
CN111718316A (zh) * 2020-07-02 2020-09-29 无锡紫杉药业有限公司 一种三水多西他赛生产工艺
AU2022443487B2 (en) 2022-02-25 2026-05-21 Zhuhai Beihai Biotech Co., Ltd. Taxotere composition and method

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2696459B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
FR2703049B1 (fr) * 1993-03-22 1995-04-21 Rhone Poulenc Rorer Sa Procédé de purification des taxoïdes.
JP3623531B2 (ja) * 1993-06-07 2005-02-23 ビーエーエスエフ アクチェンゲゼルシャフト 結晶質l−アスコルビン酸−2−燐酸エステルマグネシウム塩の製造法
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
US5688977A (en) * 1996-02-29 1997-11-18 Napro Biotherapeutics, Inc. Method for docetaxel synthesis
US5917062A (en) * 1997-11-21 1999-06-29 Indena S.P.A Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
US6531611B2 (en) 2001-03-23 2003-03-11 Scinopharm Taiwan, Ltd. Process for making taxane derivatives
US6881852B2 (en) 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
DE60323079D1 (de) 2002-04-05 2008-10-02 Natural Pharmaceuticals Inc Umwandlung von taxanmolekülen
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
US6956123B2 (en) 2003-03-17 2005-10-18 Natural Pharmaccuticals, Inc. Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins
CN1268619C (zh) * 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
EP1947094A3 (en) * 2003-12-12 2009-02-18 Quiral Quimica Do Brasil Process for the preparation of taxane derivatives
WO2005061747A1 (ja) 2003-12-19 2005-07-07 Daido Steel Co.,Ltd 耐溶損性に優れた熱間工具鋼及び金型部材
WO2007044950A2 (en) * 2005-10-12 2007-04-19 Sicor, Inc. Crystalline forms of docetaxel and processes for their preparation
KR100995390B1 (ko) * 2006-01-02 2010-11-19 주식회사 삼양제넥스 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
KR20080100264A (ko) 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법

Similar Documents

Publication Publication Date Title
RU2012138892A (ru) СОЛИ И ПОЛИМОРФЫ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5,-ТЕТРАГИДРО-6Н-АЗЕПИНО[5,4,3-cd]ИНДОЛ-6-ОНА
CN1227233C (zh) 纯晶形的5-氯-3-(4-甲磺酰基苯基)-6′-甲基-[2,3′]联吡啶及其合成方法
JP2010506932A (ja) 結晶性の無水ドセタキセルの製造方法
JP2016528179A5 (cg-RX-API-DMAC7.html)
JP2020536893A5 (cg-RX-API-DMAC7.html)
JP2013503134A5 (cg-RX-API-DMAC7.html)
RU2015103065A (ru) Кристаллическая форма i дималеата ингибитора тирозинкиназы и способ ее получения
JP2007532548A5 (cg-RX-API-DMAC7.html)
JP2018534289A5 (cg-RX-API-DMAC7.html)
JP2018531280A5 (cg-RX-API-DMAC7.html)
JP2022517675A5 (cg-RX-API-DMAC7.html)
RU2022109286A (ru) Кристаллическая форма гидрата свободного основания лорлатиниба
JP2015516425A5 (cg-RX-API-DMAC7.html)
JP2011515421A5 (cg-RX-API-DMAC7.html)
JP2003527319A5 (cg-RX-API-DMAC7.html)
JP2013520488A5 (cg-RX-API-DMAC7.html)
JP2005529084A5 (cg-RX-API-DMAC7.html)
JP2023530785A5 (cg-RX-API-DMAC7.html)
CN102399200B (zh) 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
JP2023530786A5 (cg-RX-API-DMAC7.html)
JP2016510767A5 (cg-RX-API-DMAC7.html)
JP6059734B2 (ja) 2−アルキル−又は2−アリール−置換タンシノン誘導体、その調製方法及び適用
CN101686968B (zh) 7-乙基-10-羟基喜树碱的多晶型物
JP2010540440A5 (cg-RX-API-DMAC7.html)
TW201838998A (zh) 製備吲哚啉苯并二氮平衍生物之方法